Literature DB >> 1705976

Cellular H- and M-type lactate dehydrogenase (LDH) isoenzymes and tumour diagnosis--an immunohistochemical assessment.

L X Pan1, J N Xu, P G Isaacson.   

Abstract

Cellular H- and M-type lactate dehydrogenase (LDH) isoenzymes were determined immunohistochemically in a wide range of normal, inflammatory, benign neoplastic, and malignant tissues to assess the possible value of the isoenzymes in tumour diagnosis. Both types of LDH were detected almost ubiquitously in normal tissues. Increased staining intensity of LDH, especially M-type LDH, was demonstrated in most types of malignant tumours studied. Similar increased staining intensity of the isoenzymes was also noted to parallel the proliferative activity of the cells in non-neoplastic diseases and benign neoplasms. The results suggest that changes of cellular H- and M-type LDH isoenzymes are not specific for any type of malignant tumours. The increase in cellular H- and M-type LDH isoenzymes appears to be related to proliferation of cells in general.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705976     DOI: 10.1002/path.1711630110

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  3 in total

1.  Lactate dehydrogenase (LDH) isoenzymes and proliferative activity of lymphoid cells--an immunocytochemical study.

Authors:  L Pan; P C Beverley; P G Isaacson
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

2.  Comparative Proteome Analysis of Breast Cancer Tissues Highlights the Importance of Glycerol-3-phosphate Dehydrogenase 1 and Monoacylglycerol Lipase in Breast Cancer Metabolism.

Authors:  Kubra Karaosmanoglu Yoneten; Murat Kasap; Gurler Akpinar; Abdullah Gunes; Bora Gurel; Nihat Zafer Utkan
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

3.  The comparison of spontaneous LDH release activity from cultured PBMC with sera LDH activity in non-Hodgkin's lymphoma patients.

Authors:  V Jurisić; G Konjević; R Jancić-Nedeljkov; M Sretenović; B Banicević; M Colović; I Spuzić
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.